A fusion protein derived from plants holds promising potential as a new oral therapy for type 2 diabetes
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A fusion protein derived from plants holds promising potential as a new oral therapy for type 2 diabetes
Authors
Keywords
-
Journal
PLANT BIOTECHNOLOGY JOURNAL
Volume 12, Issue 4, Pages 425-435
Publisher
Wiley
Online
2013-12-30
DOI
10.1111/pbi.12149
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Is Incretin-Based Therapy Ready for the Care of Hospitalized Patients With Type 2 Diabetes?: The time has come for GLP-1 receptor agonists!
- (2013) S. Schwartz et al. DIABETES CARE
- Downregulation of Fas activity rescues early onset of diabetes in c-KitWv/+ mice
- (2012) Zhi-Chao Feng et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The incretin hormones: from scientific discovery to practical therapeutics
- (2012) S. Mudaliar et al. DIABETOLOGIA
- Critical role of c-Kit in beta cell function: increased insulin secretion and protection against diabetes in a mouse model
- (2012) Z. C. Feng et al. DIABETOLOGIA
- Inhibition of Gsk3β activity improves β-cell function in c-KitWv/+ male mice
- (2012) Zhi-Chao Feng et al. LABORATORY INVESTIGATION
- Mass spectrometry study of a transferrin-based protein drug reveals the key role of protein aggregation for successful oral delivery
- (2012) C. E. Bobst et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Exendin-4 Protects MIN6 Cells from t-BHP-Induced Apoptosis via IRE1-JNK-Caspase-3 Signaling
- (2012) Wen-Jia Chen et al. International Journal of Endocrinology
- Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting
- (2011) Gary S Collins et al. BMC Medicine
- Cardiovascular Complications in Diabetes: Lessons from Animal Models
- (2011) M. A. Potenza et al. CURRENT MEDICINAL CHEMISTRY
- Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A review of their efficacy and tolerability
- (2011) A. J. Garber DIABETES CARE
- Effects of Receptor Binding on Plasma Half-Life of Bifunctional Transferrin Fusion Proteins
- (2011) Xiaoying Chen et al. MOLECULAR PHARMACEUTICS
- Endocrine disruptors in the etiology of type 2 diabetes mellitus
- (2011) Paloma Alonso-Magdalena et al. Nature Reviews Endocrinology
- Incretin-based therapy: a powerful and promising weapon in the treatment of type 2 diabetes mellitus
- (2011) Chrysi Koliaki et al. Diabetes Therapy
- Recombinant human transferrin: Beyond iron binding and transport
- (2010) Martin E. Brandsma et al. BIOTECHNOLOGY ADVANCES
- Global healthcare expenditure on diabetes for 2010 and 2030
- (2010) Ping Zhang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Transferrin Fusion Technology: A Novel Approach to Prolonging Biological Half-Life of Insulinotropic Peptides
- (2010) B.-J. Kim et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Plant-derived recombinant human serum transferrin demonstrates multiple functions
- (2010) Martin E. Brandsma et al. PLANT BIOTECHNOLOGY JOURNAL
- Expression, purification, and characterization of recombinant human transferrin from rice (Oryza sativa L.)
- (2010) Deshui Zhang et al. PROTEIN EXPRESSION AND PURIFICATION
- High-yield expression of recombinant soybean agglutinin in plants using transient and stable systems
- (2010) Reynald Tremblay et al. TRANSGENIC RESEARCH
- A review of exenatide as adjunctive therapy in patients with type 2 diabetes
- (2010) Gisela Robles Drug Design Development and Therapy
- Tobacco, a highly efficient green bioreactor for production of therapeutic proteins
- (2009) Reynald Tremblay et al. BIOTECHNOLOGY ADVANCES
- Protein and peptide drug delivery: Oral approaches
- (2009) Jessy Shaji et al. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Human growth hormone–transferrin fusion protein for oral delivery in hypophysectomized rats
- (2009) Nurmamet Amet et al. JOURNAL OF CONTROLLED RELEASE
- Incretin-based therapies for type 2 diabetes mellitus
- (2009) Julie A. Lovshin et al. Nature Reviews Endocrinology
- A novel platform for biologically active recombinant human interleukin-13 production
- (2008) David J. Wang et al. PLANT BIOTECHNOLOGY JOURNAL
- Exendin-4 Modulates Diabetes Onset in Nonobese Diabetic Mice
- (2007) Irene Hadjiyanni et al. ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now